Genetic Analysis in Fetal Skeletal Dysplasias by Trio Whole-Exome Sequencing

Abstract EN

Skeletal dysplasias (SDs) comprise a series of severe congenital disorders that have strong clinical heterogeneity and usually attribute to diverse genetic variations.

The pathogenesis of more than half of SDs remains unclear.

Additionally, the clinical manifestations of fetal SDs are ambiguous, which poses a big challenge for accurate diagnosis.

In this study, eight unrelated families with fetal SD were recruited and subjected to sequential tests including chromosomal karyotyping, chromosomal microarray analysis (CMA), and trio whole-exome sequencing (WES).

Sanger sequencing and quantitative fluorescence PCR (QF-PCR) were performed as affirmative experiments.

In six families, a total of six pathogenic/likely pathogenic variations were identified in four genes including SLC26A2, FGFR3, FLNB, and TMEM38B.

These variations caused disorders following autosomal dominant or autosomal recessive inheritance patterns, respectively.

The results provided reliable evidence for the subsequent genetic counseling and reproductive options to these families.

With its advantage in variation calling and interpreting, trio WES is a promising strategy for the investigation of fetal SDs in cases with normal karyotyping and CMA results.

It has considerable prospects to be utilized in prenatal diagnosis.